[1][2] Participants give consent for their genome data to be linked to information about their medical condition and health records.
The medical and genomic data is shared with researchers to improve knowledge of the causes, treatment, and care of diseases.
In 2015, Northern Ireland[6] and Scotland[7] also joined the project with plans to start work the following year.
[10] In September 2015, Genomics England announced it had contracted with interpretation partners Congenica and Omicia.
[17][18] The Genomics England Clinical Interpretation Partnership (GeCIP) includes 2,500 UK and international clinicians and scientists from approximately 300 institutions in 24 countries.
The partnership is integrated with the NHS and the aims include improving the use of genotype and phenotype data in healthcare, and providing a platform for genomic research collaborations to add to the knowledge base for genetic disorders.